GlassScriptPhysician profile
Mamta Tarak Choksi
NPI 1780644351
$34,815.93
in general payments reported to CMS, 2019-2025
86 companies · $4,019 in 2025
The $4,019 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,121 · 2020: $3,210 · 2021: $3,644 · 2022: $2,550 · 2023: $11K · 2024: $3,025 · 2025: $4,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,775 · Consulting Fee: $7,595 · Travel and Lodging: $478 · Education: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,775.48 |
| Consulting Fee | $7,595.00 |
| Travel and Lodging | $477.79 |
| Education | $443.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunogen, INC. | $7,742.44 | 2023 | Elahere |
| Verastem, INC. | $3,283.61 | 2019 | |
| Celgene Corporation | $3,152.98 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Array Biopharma INC | $2,064.11 | 2019-2024 | Braftovi, Mektovi, Lorbrena |
| E.R. Squibb & Sons, L.L.C. | $1,782.95 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Bayer Healthcare Pharmaceuticals INC. | $1,462.94 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,386.10 | 2019-2025 | |
| Janssen Biotech, INC. | $1,106.84 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Merck Sharp & Dohme LLC | $925.45 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pfizer INC. | $775.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $710.36 | 2019-2025 | Lynparza, Enhertu, Calquence |
| Gilead Sciences, INC. | $690.98 | 2019-2025 | Trodelvy |
| Genzyme Corporation | $653.32 | 2019-2025 | |
| Genentech USA, INC. | $626.54 | 2019-2023 | Venclexta, Phesgo, Perjeta |
| Tersera Therapeutics LLC | $615.08 | 2019-2025 | Zoladex |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $563.80 | 2019-2025 | Venclexta |
| Seagen INC. | $541.37 | 2019-2025 | Adcetris, Tivdak |
| Glaxosmithkline, LLC. | $452.61 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Amgen INC. | $407.91 | 2019-2023 | Xgeva, Vectibix, Nplate |
| Exelixis INC. | $404.81 | 2019-2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $389.74 | 2019-2025 | Libtayo |
| Incyte Corporation | $387.37 | 2020-2025 | Jakafi, Monjuvi, Zynyz |
| Daiichi Sankyo INC. | $381.34 | 2019-2025 | Enhertu, Injectafer |
| Lilly USA, LLC | $378.39 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Beigene USA, INC. | $270.47 | 2021-2024 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $251.20 | 2019-2025 | Fruzaqla, Alunbrig |
| Kite Pharma, INC. | $235.51 | 2020-2025 | Yescarta |
| Pharmacyclics LLC, An Abbvie Company | $208.53 | 2020-2023 | Imbruvica |
| Puma Biotechnology, INC. | $151.82 | 2019-2025 | |
| Legend Biotech USA INC. | $138.57 | 2024-2025 | Carvykti |
| Astellas Pharma US INC | $124.89 | 2019-2025 | Vyloy |
| Adaptive Biotechnologies Corporation | $119.32 | 2019 | |
| Rigel Pharmaceuticals, INC. | $115.77 | 2020-2023 | Tavalisse, Rezlidhia |
| Agios Pharmaceuticals, INC. | $113.32 | 2019-2025 | Pyrukynd |
| Eisai INC. | $105.41 | 2020-2025 | |
| Mirati Therapeutics, INC. | $103.59 | 2023-2024 | Krazati |
| Jazz Pharmaceuticals INC. | $97.56 | 2022-2024 | Zepzelca |
| Servier Pharmaceuticals LLC | $94.60 | 2021-2025 | |
| Kyowa Kirin, INC. | $90.54 | 2020-2025 | |
| Sobi, INC | $89.99 | 2024 | |
| Emd Serono, INC. | $83.97 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $82.26 | 2019-2022 | |
| Karyopharm Therapeutics INC. | $78.56 | 2020 | |
| Stemline Therapeutics INC. | $71.12 | 2023-2025 | Orserdu |
| Blueprint Medicines Corporation | $67.15 | 2020-2023 | Ayvakit |
| Taiho Oncology, INC. | $61.01 | 2023-2025 | |
| Aveo Pharmaceuticals, INC. | $60.20 | 2021-2025 | |
| Pharmaessentia USA Corporation | $60.03 | 2024-2025 | Besremi |
| Dendreon Pharmaceuticals LLC | $59.12 | 2022-2024 | Provenge |
| Alexion Pharmaceuticals, INC. | $58.99 | 2019-2024 | Ultomiris |
| Medtronic Vascular, INC. | $56.72 | 2020 | |
| Morphosys, US INC. | $52.02 | 2021-2023 | Monjuvi |
| Ipsen Biopharmaceuticals, INC | $47.14 | 2019-2021 | |
| Tempus Ai, INC | $44.32 | 2024 | Xt Cdx |
| Geron Corporation | $41.86 | 2025 | Rytelo |
| Genmab U.S., INC. | $41.77 | 2023 | Epkinly |
| Tesaro, INC. | $41.34 | 2019 | |
| Csl Behring | $40.13 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.59 | 2020-2022 | |
| Deciphera Pharmaceuticals INC. | $32.06 | 2021 | |
| Recordati_rare_diseases_inc. | $31.67 | 2025 | Enjaymo |
| Beone Medicines USA, INC. | $31.17 | 2025 | Brukinsa |
| Myovant Sciences INC. | $29.67 | 2021 | |
| G1 Therapeutics, INC. | $29.05 | 2022-2023 | Cosela |
| Springworks Therapeutics, INC. | $28.06 | 2025 | Ogsiveo |
| Cti Biopharma Corp. | $27.93 | 2022-2023 | Vonjo |
| Iovance Biotherapeutics, INC. | $27.89 | 2025 | Amtagvi |
| Epizyme, INC. | $26.29 | 2021 | |
| Fennec Pharmaceuticals, INC. | $25.24 | 2024 | Pedmark |
| Lexicon Pharmaceuticals, INC. | $22.92 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $18.63 | 2020 | |
| Eusa Pharma (US) LLC | $18.63 | 2022 | |
| Ethicon US, LLC | $17.81 | 2019 | |
| Apellis Pharmaceuticals, INC. | $16.86 | 2023 | Empaveli |
| Syndax Pharmaceuticals, INC. | $16.64 | 2025 | |
| Hologic Sales and Service, LLC | $16.56 | 2023 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Ge Healthcare | $15.72 | 2022 | |
| Novocure INC. | $15.59 | 2019 | |
| Adc Therapeutics America, INC. | $15.40 | 2023 | |
| Global Blood Therapeutics, INC. | $14.16 | 2022 | |
| Sumitomo Pharma America, INC. | $14.10 | 2023 | Orgovyx |
| Shire North American Group INC | $13.92 | 2019 | |
| Aurobindo Pharma USA, INC. | $13.11 | 2019 | |
| Myriad Genetic Laboratories, INC. | $11.44 | 2022 | |
| Adma Biomanufacturing LLC | $4.05 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mamta Choksi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.